APA (7th ed.) Citation

Lee, Y. J., Chung, Y. S., Lee, J., Nam, E. J., Kim, S. W., Kim, S., & Kim, Y. T. (2019, February). Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer. Cancer Medicine.

Chicago Style (17th ed.) Citation

Lee, Yong Jae, Young Shin Chung, Jung‐Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, and Young Tae Kim. "Pretreatment Lymphocytopenia Is an Adverse Prognostic Biomarker in Advanced‐stage Ovarian Cancer." Cancer Medicine Feb. 2019.

MLA (9th ed.) Citation

Lee, Yong Jae, et al. "Pretreatment Lymphocytopenia Is an Adverse Prognostic Biomarker in Advanced‐stage Ovarian Cancer." Cancer Medicine, Feb. 2019.